Allogene Therapeutics, Inc.
ALLO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737287
In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Allogene Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 176 | 171 | −5 |
| Shares | 117.9M | 133.4M | +15.5M (+13.2%) |
| Value | $582.3M | $662.9M | +$80.5M (+13.8%) |
New holders (22)
Institutions that held Allogene Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Man Group plc | 220,307 | $1.09M | 0.00% |
| Alps Advisors Inc | 107,203 | $532.8K | 0.00% |
| Schonfeld Strategic Advisors LLC | 102,285 | $508.4K | 0.00% |
| Mackenzie Financial Corp | 53,192 | $263.8K | 0.00% |
| Los Angeles Capital Management LLC | 41,227 | $204.9K | 0.00% |
| Dynamic Technology Lab Private Ltd | 33,095 | $164.0K | 0.02% |
| AXA S.A. | 28,300 | $140.7K | 0.00% |
| Nebula Research & Development LLC | 26,900 | $133.7K | 0.10% |
| Exchange Traded Concepts, LLC | 24,937 | $123.9K | 0.00% |
| Franklin Resources Inc | 23,576 | $117.2K | 0.00% |
| Capstone Investment Advisors, LLC | 21,438 | $106.5K | 0.00% |
| LPL Financial LLC | 20,850 | $103.6K | 0.00% |
| Campbell & CO Investment Adviser LLC | 18,952 | $94.2K | 0.02% |
| Inceptionr LLC | 16,203 | $80.5K | 0.04% |
| Orin Green Financial, LLC | 15,990 | $79.5K | 0.04% |
| Bayesian Capital Management, LP | 14,100 | $70.1K | 0.01% |
| Oppenheimer & Co Inc | 12,400 | $61.6K | 0.00% |
| Crosspoint Financial, LLC | 12,000 | $59.6K | 0.61% |
| Tudor Investment Corp Et Al | 10,863 | $54.0K | 0.00% |
| Itau Unibanco Holding S.A. | 3,544 | $17.6K | 0.00% |
| Allworth Financial LP | 60 | $299 | 0.00% |
| CWM, LLC | 27 | $0 | 0.00% |
Sold out (27)
Institutions that held Allogene Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.